Misc
Safety
Study 1
Study 2
Lumateperone
100

The patient population was the same for schizophrenia studies as it was for Bipolar studies - True or False 

What is false

100

The majority of TEAEs were considered 

What is mild to moderate? 

100

what is the change in MADRS score at day 43

The Primary End Point

100

There were 2 drugs tested in the adjunct study.

What is valproate and Lithium

100

The ONLY drug that has an indication for BP 1 and BP2 both monotherapy and adjuctive.

What is CAPLYTA? 

200

Patients were included that had what diagnosis?

What is BiPolar 1 and BiPolar 2

200

Metabolic, weight and EPS profiles were shown to be...

what is favorable

200

Study included data that was considered to be collected from many studies, this term is called? 

what is pooled data.

200

This was the placebo subtracted difference in the change from baseline MADRS score

what is 2.4

200

High binding affinity for what reception? 

What is 5HT2A

300

Which Region will out-work the other Regions in the South Central Area and the Nation?

The South Central Region....bar none! 

300

Top 3 common AE's were?

what is Headache, somnolence, dizziness and nausea

300

In this trial, Lumateperone demonstrated a ______________________ from baseline in MADRS score. 

what is a 16.7 decrease

300

The key secondary endpoint for Lumateperone and lithium or valproate showed a significant drop of? 

What is 1.8? 

300

We will focus on a Primary call for _____________________ and a secondary call for __________________________

What is BP indication, schizophrenia indication 

400

CAPLYTA for BPD is dosed 

what is 42 mg any time of day with or without food

400

Solmnolence rate in Study 2 vs placebo was? 

13% vs 3%

400

At the end of the 6-week study. lumateperone demonstrated _____________________ ________________________ ________________ in MADRS compared to placebo

what is a statistically significant reduction 

400

This drug was considered the adjunct in the study

what is Caplyta

400

Akathisia for monotherapy trials was ____ vs ____

what is 1 vs .3

500

How many patients in the BP 6 week trials experienced a manic episode during the trials?

None, zero nada, zilch

500

Data collected from 2 studies (study 1 and 2) plus one failed trial is considered? 

What is pooled data

500
This was the key secondary endpoint

what change in baseline in CGI-BP-S total score and depression score 

500

What was the mean MADRS score of the patients in the syudy

what is 32

500

How many TEAEs led to discontinuation in 2% of patients? 

What is NONE

M
e
n
u